
    
      All subjects will be followed up for 60 days post-randomization and through the influenza
      season. Following the influenza season, a subset of the subjects will receive a booster
      vaccine at the 12 month time point. The subjects will further be assessed at 2 days, 7 days,
      15 days, 30 days and 6 months following the booster vaccination.
    
  